Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
177Lu-PSMA radioligand therapy of predominant lymph node metastatic prostate cancer.
von Eyben FE, Singh A, Zhang J, Nipsch K, Meyrick D, Lenzo N, Kairemo K, Joensuu T, Virgolini I, Soydal C, Kulkarni HR, Baum RP. von Eyben FE, et al. Among authors: kairemo k. Oncotarget. 2019 Mar 29;10(25):2451-2461. doi: 10.18632/oncotarget.26789. eCollection 2019 Mar 29. Oncotarget. 2019. PMID: 31069008 Free PMC article.
Adjuvant radiotherapy for lymph-node positive prostate cancer.
von Eyben FE, Kairemo K, Kiljunen T, Joensuu T. von Eyben FE, et al. Among authors: kairemo k. BJU Int. 2015 Mar;115(3):353-5. doi: 10.1111/bju.12659. Epub 2014 May 22. BJU Int. 2015. PMID: 24854603 No abstract available.
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy.
Hemminki O, Parviainen S, Juhila J, Turkki R, Linder N, Lundin J, Kankainen M, Ristimäki A, Koski A, Liikanen I, Oksanen M, Nettelbeck DM, Kairemo K, Partanen K, Joensuu T, Kanerva A, Hemminki A. Hemminki O, et al. Among authors: kairemo k. Oncotarget. 2015 Feb 28;6(6):4467-81. doi: 10.18632/oncotarget.2901. Oncotarget. 2015. PMID: 25714011 Free PMC article. Clinical Trial.
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.
Liikanen I, Koski A, Merisalo-Soikkeli M, Hemminki O, Oksanen M, Kairemo K, Joensuu T, Kanerva A, Hemminki A. Liikanen I, et al. Among authors: kairemo k. Oncoimmunology. 2015 Apr 2;4(3):e989771. doi: 10.4161/2162402X.2014.989771. eCollection 2015 Mar. Oncoimmunology. 2015. PMID: 25949903 Free PMC article.
Management of advanced prostate cancer.
von Eyben F, Kiljunen T, Kangasmaki A, Kairemo K, von Eyben R, Joensuu T. von Eyben F, et al. Among authors: kairemo k. Ann Oncol. 2015 Nov;26(11):2354. doi: 10.1093/annonc/mdv327. Epub 2015 Jul 27. Ann Oncol. 2015. PMID: 26216387 Free article. No abstract available.
185 results